397 related articles for article (PubMed ID: 21315704)
1. An overview of a recent court challenge to the protection of biomarkers as intellectual property.
Hall SC; Tromp JM; Jortani SA
Clin Chim Acta; 2011 May; 412(11-12):802-5. PubMed ID: 21315704
[TBL] [Abstract][Full Text] [Related]
2. [Opposition to Myriad Genetics patents and their total or partial revocation in Europe: early conclusions].
Cassier M; Stoppa-Lyonnet D
Med Sci (Paris); 2005; 21(6-7):658-62. PubMed ID: 15985212
[TBL] [Abstract][Full Text] [Related]
3. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing.
Bergin C
Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200
[TBL] [Abstract][Full Text] [Related]
4. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
5. Patenting DNA.
Bobrow M; Thomas S
Curr Opin Mol Ther; 2002 Dec; 4(6):542-7. PubMed ID: 12596355
[TBL] [Abstract][Full Text] [Related]
6. [Patents on life? No patent on life!].
van Raden L
Dtsch Tierarztl Wochenschr; 1998 Mar; 105(3):90-3. PubMed ID: 9581373
[TBL] [Abstract][Full Text] [Related]
7. Patenting for the research scientist: an update.
Crespi RS
Trends Biotechnol; 2004 Dec; 22(12):638-42. PubMed ID: 15542154
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
Abbot J
J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of biomarker patents in personalized medicine.
Kesselheim AS; Shiu N
Clin Pharmacol Ther; 2014 Feb; 95(2):127-9. PubMed ID: 24448456
[TBL] [Abstract][Full Text] [Related]
10. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research.
Matthews KR; Cuchiara ML
Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060
[TBL] [Abstract][Full Text] [Related]
11. Innovations and intellectual property: the case of genomic patenting.
Jackson BA
J Policy Anal Manage; 2003; 22(1):5-25. PubMed ID: 12722760
[TBL] [Abstract][Full Text] [Related]
12. Inventions and Patents: A Practical Tutorial.
Mehta H; Tidwell L; Liotta LA
Methods Mol Biol; 2017; 1606():379-397. PubMed ID: 28502014
[TBL] [Abstract][Full Text] [Related]
13. Patenting inventions in the field of biology and chemistry: German and European patent law and case law.
Vossius V
Naturwissenschaften; 1997 Oct; 84(10):431-43. PubMed ID: 9394296
[TBL] [Abstract][Full Text] [Related]
14. European opposition to exclusive control over predictive breast cancer testing and the inherent implications for U.S. patent law and public policy: a case study of the Myriad Genetics' BRCA patent controversy.
Paradise J
Food Drug Law J; 2004; 59(1):133-54. PubMed ID: 15190928
[No Abstract] [Full Text] [Related]
15. Patenting biotechnologies: the European Union Directive 98/44/EC of the European parliament and of the council of 6th July 1998 on the legal protection of biotechnological inventions.
Morelli Gradi G
Forum (Genova); 1999; 9(3 Suppl 3):25-36. PubMed ID: 10607844
[TBL] [Abstract][Full Text] [Related]
16. Patentability and maximum protection of intellectual property in proteomics and genomics.
Warburg RJ; Wellman A; Buck TB; Ligler Schoenhard A
Pharmacogenomics; 2003 Jan; 4(1):81-90. PubMed ID: 12517288
[TBL] [Abstract][Full Text] [Related]
17. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
Aymé S; Matthijs G; Soini S;
Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
[TBL] [Abstract][Full Text] [Related]
18. Some Legal Issues Regarding the Patenting of Human Genetic Materials.
MacFarlane P; Kontoleon B
J Law Med; 2016; 24(1):181-202. PubMed ID: 30136781
[TBL] [Abstract][Full Text] [Related]
19. Patent border wars: defining the boundary between scientific discoveries and patentable inventions.
Holman CM
Trends Biotechnol; 2007 Dec; 25(12):539-43. PubMed ID: 17983675
[TBL] [Abstract][Full Text] [Related]
20. Something more is necessary: are genes and genetic diagnostic tests statutory subject matter for US patents?
Cockbain J; Sterckx S
Expert Rev Mol Diagn; 2011 Mar; 11(2):149-58. PubMed ID: 21405966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
